AU2007272441A1 - Antiviral agents - Google Patents

Antiviral agents Download PDF

Info

Publication number
AU2007272441A1
AU2007272441A1 AU2007272441A AU2007272441A AU2007272441A1 AU 2007272441 A1 AU2007272441 A1 AU 2007272441A1 AU 2007272441 A AU2007272441 A AU 2007272441A AU 2007272441 A AU2007272441 A AU 2007272441A AU 2007272441 A1 AU2007272441 A1 AU 2007272441A1
Authority
AU
Australia
Prior art keywords
substituted
carbonylmethyl
methyl
amino
compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2007272441A
Other languages
English (en)
Other versions
AU2007272441A2 (en
Inventor
Janos Botyanszki
Ronald Conrad Griffith
Son Minh Pham
Christopher Don Roberts
Franz Ulrich Schmitz
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SmithKline Beecham Corp
Original Assignee
Genelabs Technologies Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genelabs Technologies Inc filed Critical Genelabs Technologies Inc
Publication of AU2007272441A1 publication Critical patent/AU2007272441A1/en
Publication of AU2007272441A2 publication Critical patent/AU2007272441A2/en
Assigned to SMITHKLINE BEECHAM CORPORATION reassignment SMITHKLINE BEECHAM CORPORATION Request for Assignment Assignors: GENELABS TECHNOLOGIES, INC.
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/407—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with other heterocyclic ring systems, e.g. ketorolac, physostigmine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Virology (AREA)
  • Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
AU2007272441A 2006-07-14 2007-07-12 Antiviral agents Abandoned AU2007272441A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US83104006P 2006-07-14 2006-07-14
US60/831,040 2006-07-14
PCT/US2007/073391 WO2008008912A1 (en) 2006-07-14 2007-07-12 Antiviral agents

Publications (2)

Publication Number Publication Date
AU2007272441A1 true AU2007272441A1 (en) 2008-01-17
AU2007272441A2 AU2007272441A2 (en) 2009-03-19

Family

ID=38742551

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2007272441A Abandoned AU2007272441A1 (en) 2006-07-14 2007-07-12 Antiviral agents

Country Status (13)

Country Link
EP (1) EP2044083A1 (ko)
JP (1) JP2009543807A (ko)
KR (1) KR20090033881A (ko)
CN (1) CN101490058A (ko)
AR (1) AR062258A1 (ko)
AU (1) AU2007272441A1 (ko)
BR (1) BRPI0714346A2 (ko)
CA (1) CA2657651A1 (ko)
MX (1) MX2009000513A (ko)
PE (1) PE20080427A1 (ko)
RU (1) RU2009105196A (ko)
TW (1) TW200813070A (ko)
WO (2) WO2008008907A2 (ko)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070049593A1 (en) 2004-02-24 2007-03-01 Japan Tobacco Inc. Tetracyclic fused heterocyclic compound and use thereof as HCV polymerase inhibitor
US7659263B2 (en) 2004-11-12 2010-02-09 Japan Tobacco Inc. Thienopyrrole compound and use thereof as HCV polymerase inhibitor
WO2008137126A2 (en) 2007-05-04 2008-11-13 Vertex Pharmaceuticals Incorporated Combination therapy for the treatment of hcv infection
AR079528A1 (es) 2009-12-18 2012-02-01 Idenix Pharmaceuticals Inc Inhibidores de arileno o heteroarileno 5,5-fusionado del virus de la hepatitis c
EP2655362A1 (en) * 2010-12-22 2013-10-30 Abbvie Inc. Hepatitis c inhibitors and uses thereof
US20120252721A1 (en) * 2011-03-31 2012-10-04 Idenix Pharmaceuticals, Inc. Methods for treating drug-resistant hepatitis c virus infection with a 5,5-fused arylene or heteroarylene hepatitis c virus inhibitor
FR3008975A1 (fr) 2013-07-23 2015-01-30 Servier Lab Nouveaux derives de pyrrole, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
RU2546006C1 (ru) 2014-03-07 2015-04-10 Римма Ильинична Ашкинази Противовирусное средство
US10080728B2 (en) 2015-01-20 2018-09-25 Viktor Veniaminovich Tets Hemostatic agent
US10167293B2 (en) * 2016-05-26 2019-01-01 Bayer Pharma Aktiengesellschaft [8-(phenylsulfonyl)-3,8-diazabicyclo[3.2.1]oct-3-yl](1H-1,2,3-triazol-4-yl)methanones
CA3064733A1 (en) 2017-05-24 2018-11-29 Viktor Veniaminovich Tets Fractionated antimicrobial compositions and use thereof
US11661431B2 (en) 2021-04-16 2023-05-30 Gilead Sciences, Inc. Thienopyrrole compounds
EP4398989A1 (en) 2021-09-10 2024-07-17 Gilead Sciences, Inc. Thienopyrrole compounds

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR0210357A (pt) * 2001-06-11 2004-06-29 Shire Biochem Inc Composto e métodos para o tratamento ou a prevenção de infecções pelo flavivìrus
ZA200509590B (en) * 2003-06-04 2007-04-25 Genelabs Tech Inc Nitrogen-containing heteroaryl derivatives for the treatment of HCV-infection

Also Published As

Publication number Publication date
AR062258A1 (es) 2008-10-29
MX2009000513A (es) 2009-03-09
PE20080427A1 (es) 2008-06-11
RU2009105196A (ru) 2010-08-27
EP2044083A1 (en) 2009-04-08
CA2657651A1 (en) 2008-01-17
WO2008008912A1 (en) 2008-01-17
BRPI0714346A2 (pt) 2013-03-19
WO2008008907A3 (en) 2008-03-20
CN101490058A (zh) 2009-07-22
TW200813070A (en) 2008-03-16
AU2007272441A2 (en) 2009-03-19
WO2008008907A2 (en) 2008-01-17
KR20090033881A (ko) 2009-04-06
JP2009543807A (ja) 2009-12-10

Similar Documents

Publication Publication Date Title
AU2007272441A1 (en) Antiviral agents
US20060211698A1 (en) Bicyclic heteroaryl derivatives for treating viruses
CA2613261A1 (en) Heteroaryl derivatives for treating viruses
US20070032488A1 (en) 6-Membered aryl and heteroaryl derivatives for treating viruses
WO2008070447A2 (en) Anti-viral compounds
AU2007275276A1 (en) Polycyclic viral inhibitors
AU2006326494A1 (en) N-(6-membered aromatic ring)-amido anti-viral compounds
WO2008154601A1 (en) Anti-viral inhibitors and methods of use
AU2006326443A1 (en) N-(5-membered heteroaromatic ring)-amido anti-viral compounds
KR20100056462A (ko) 항바이러스 화합물, 조성물 및 용도
US20080051384A1 (en) Antiviral agents
US9533999B2 (en) Fused thiazin-3-ones as KCA3.1 inhibitors
WO2010081149A1 (en) Anti-viral compounds, compositions, and methods of use

Legal Events

Date Code Title Description
DA3 Amendments made section 104

Free format text: THE NATURE OF THE AMENDMENT IS AS SHOWN IN THE STATEMENT(S) FILED 18 FEB 2009

PC1 Assignment before grant (sect. 113)

Owner name: SMITHKLINE BEECHAM CORPORATION

Free format text: FORMER APPLICANT(S): GENELABS TECHNOLOGIES, INC.

MK1 Application lapsed section 142(2)(a) - no request for examination in relevant period